Serum Institute says claims surrounding COVID-19 vaccine COVISHIELD’s availability in 73 days are false

Serum Institute of India (SSI), which has entered a manufacturing partnership with AstraZeneca to produce Oxford University’s Covid-19 vaccine candidate, has denied reports that the shot may be launched in 73 days as “completely false and conjectural”.  The Pune-based institute has said that Covishield, the Oxford University-Astra Zeneca vaccine candidate, will be commercialized once trials are proven successful and requisite regulatory approvals are in place.




Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *